bourse

#Pharma ailleurs #Bourse Bon pour #Sanofi aux USA - Novo In Need Of A Booster Shot - http://t.co/xExw1tlxGD cc @MTU31 jallatte (@jallatte) July 05, 2013 The once-unstoppable Novo Nordisk ( NVO) has hit a bad patch, its shares defying big-cap market trends...

#Pharma #Bourse Imperial Innovations pulls in £30 million from EIB to invest in #biotech http://t.co/7C8gAruGnv cc @ghabault jallatte (@jallatte) July 05, 2013 AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that...

#Pharma #Bourse #Biotech Cardio3 prices IPO at 16.65 euros per share | Reuters http://t.co/z9jE9LaML4 rappel @ghabault jallatte (@jallatte) July 05, 2013 BRUSSELS, July 4 (Reuters) - Belgian heart drug specialistCardio3 BioSciences prices its initial...

#Phrma #Bourse Novartis: Lucentis homologué en Europe pour traiter une maladie des yeux http://t.co/vgWwATCsIl jallatte (@jallatte) July 05, 2013 Novartis: Lucentis homologué en Europe pour traiter une maladie des yeux

#Pharma #Bourse UCB cède au russe R-Pharm son droit d’exploitation sur l’olokizumab MyPharma http://t.co/nIAi4KY44h jallatte (@jallatte) July 05, 2013 Publié le Jeudi 4 juillet 2013 La société biopharmaceutique belge UCB a annoncé avoir conclu un contrat...

#Pharma #Bourse #Crise Marc de Garidel (Ipsen) : "L'industrie #pharma risque de terminer l'année à -3%" - JDN http://t.co/q2va8MyAox jallatte (@jallatte) July 05, 2013 Le PDG d'Ipsen propose des mesures pour relancer l'industrie pharmaceutique française...

#Biotech #Bourse Onyx SEC Freezes $4.6 Million In Insider Trading Profits Tied To Attempted Pharma Acquisition - http://t.co/rNOvuPvWp8 jallatte (@jallatte) July 04, 2013

#Biotech #Bourse SEC Suspects Insider Trading in Onyx Shares - WSJ http://t.co/R5Fp7MVjHD jallatte (@jallatte) July 04, 2013 The SEC has frozen the assets of a group of unnamed traders who earned $4.6 million in potentially illegal profits by trading...

#Pharma #Bourse #Santé ailleurs China probes British drugmaker GSK - report - The West Australian http://t.co/qM0vEoViH8 jallatte (@jallatte) July 04, 2013 SHANGHAI (Reuters) - China's top economic planning agency has opened an investigation into pharmaceutical...

#Pharma #Bourse After oral care, GSK's attention now shifts to #OTC products | Business Standard http://t.co/y248XFDCZO jallatte (@jallatte) July 04, 2013 The consumer arm of British pharma major GlaxoSmithKline (GSK) is extending its popular antacid...